Bivalirudin is a short-acting anticoagulant (blood thinner) used to prevent blood clots during certain heart procedures, such as percutaneous coronary intervention (PCI) and for patients with heparin-induced thrombocytopenia (HIT). It works by directly inhibiting thrombin, a key protein in the clotting process. Given intravenously, bivalirudin has a rapid onset and a short duration of action, making it easier to control during procedures. Common side effects include bleeding, back pain, and nause
ECROBOT CO., Ltd, Business Registration Number : 220-88-71747, CEO J.W.Park, TEL : +82-2-552-7676, E-mail : E-mail : Contact us Address : (Hwanghwa B/D 11F, Yeoksam-dong)320, Gangnam-daero, Gangnam-gu, Seoul, South Korea